GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Synergy Pharmaceutical Co Ltd (SZSE:300636) » Definitions » Cyclically Adjusted Price-to-FCF

Jiangxi Synergy Pharmaceutical Co (SZSE:300636) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Jiangxi Synergy Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Jiangxi Synergy Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Synergy Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Jiangxi Synergy Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Jiangxi Synergy Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Jiangxi Synergy Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Jiangxi Synergy Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.075/115.1156*115.1156
=-0.075

Current CPI (Mar. 2025) = 115.1156.

Jiangxi Synergy Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 99.000 0.000
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201603 0.085 102.200 0.096
201606 -0.070 101.400 -0.079
201609 0.026 102.400 0.029
201612 0.095 102.600 0.107
201703 -0.093 103.200 -0.104
201706 -0.111 103.100 -0.124
201709 0.062 104.100 0.069
201712 -0.136 104.500 -0.150
201803 -0.144 105.300 -0.157
201806 -0.151 104.900 -0.166
201809 -0.155 106.600 -0.167
201812 -0.087 106.500 -0.094
201903 -0.275 107.700 -0.294
201906 -0.112 107.700 -0.120
201909 -0.132 109.800 -0.138
201912 -0.166 111.200 -0.172
202003 -0.055 112.300 -0.056
202006 -0.056 110.400 -0.058
202009 -0.121 111.700 -0.125
202012 -0.250 111.500 -0.258
202103 -0.282 112.662 -0.288
202106 -0.239 111.769 -0.246
202109 -0.184 112.215 -0.189
202112 -0.168 113.108 -0.171
202203 -0.036 114.335 -0.036
202206 -0.172 114.558 -0.173
202209 -0.122 115.339 -0.122
202212 -0.009 115.116 -0.009
202303 -0.029 115.116 -0.029
202306 0.012 114.558 0.012
202309 -0.149 115.339 -0.149
202312 0.035 114.781 0.035
202403 0.000 115.227 0.000
202406 0.072 114.781 0.072
202409 0.128 115.785 0.127
202412 0.153 114.893 0.153
202503 -0.075 115.116 -0.075

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jiangxi Synergy Pharmaceutical Co  (SZSE:300636) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Jiangxi Synergy Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Jiangxi Synergy Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangxi Synergy Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Fengxin Industrial Park, Fengxin, Jiangxi Province, Yichun, CHN, 330700
Jiangxi Synergy Pharmaceutical Co Ltd is a China-based company that engages in the production of bulk drugs and intermediates. Its main products include anti-epileptic medicines, anti-ulcer medicines, anti-pyretic analgesics, non-steroid anti-inflammatory analgesics, anti-high blood pressure medicines, and anti-depression drugs.
Executives
Pang Zheng Wei Directors, executives
Huang Guo Jun Directors, executives
Liang Zhong Cheng Directors, executives
Jiang Yuan Sen Directors, executives
Yu Shao Jiong Supervisors
Zhang Bo Securities Affairs Representative
Jiang Hui Gang Director
Wang Xiao Hua Director
Zhao Hong Liang Director

Jiangxi Synergy Pharmaceutical Co Headlines

No Headlines